Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 7/20 | 0.51 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.46 |
| ▸ | DHFR | P00374 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19397221 | 1.00 | TK1 (0.51) | TK1RNASE1DHFR | |
| SCHEMBL22912046 | 1.00 | TK1 (0.51) | TK1RNASE1DHFR | |
| SCHEMBL22912041 | 1.00 | TK1 (0.51) | TK1RNASE1DHFR | |
| SCHEMBL19401569 | 1.00 | TK1 (0.51) | TK1RNASE1DHFR | |
| SCHEMBL19401568 | 1.00 | TK1 (0.51) | TK1RNASE1DHFR | |
| SCHEMBL29967409 | 0.84 | TK1 (0.53) | TK1RNASE1DHFR | |
| SCHEMBL29967685 | 0.84 | TK1 (0.53) | TK1RNASE1DHFR | |
| SCHEMBL774219 | 0.83 | TK1 (0.53) | TK1RNASE1DHFR | |
| SCHEMBL15835049 | 0.83 | TK1 (0.53) | TK1RNASE1DHFR | |
| SCHEMBL14867212 | 0.82 | TK1 (0.57) | TK1RNASE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183701-A1 | Modified Double-Stranded RNA Agents | BANK OF AMERICA, N.A. | 2023-06-15 | — | — | US | disclosed |
| US-20230183701-A1 | Modified Double-Stranded RNA Agents | BANK OF AMERICA, N.A. | 2023-06-15 | — | — | US | disclosed |
| US-11549109-B2 | Modified double-stranded RNA agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-20220389424-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2022-12-08 | — | — | US | disclosed |
| US-11401517-B2 | Modified double-stranded RNA agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2022-08-02 | — | — | US | disclosed |
| US-20220002727-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | ALNYLAM PHARMACEUTICALS, INC. | 2022-01-06 | — | — | US | disclosed |
| US-20210017519-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2021-01-21 | — | — | US | disclosed |
| US-20190241891-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2019-08-08 | — | — | US | disclosed |
| US-20190241893-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2019-08-08 | — | — | US | disclosed |
| US-10233448-B2 | Modified double-stranded RNA agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2019-03-19 | — | — | US | disclosed |
| US-20170275626-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2017-09-28 | — | — | US | disclosed |
| US-20170275626-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2017-09-28 | — | — | US | disclosed |